Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteer

In brief

Single Ascending Dose Study

Key facts

Study ID

NCT00796965

Run by

AstraZeneca

People needed

48

Starts

2008-12-01

Expected to finish

2009-03-01

Last updated by the study team

2009-08-19

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Provision of Informed Consent
• Healthy male subjects and female subjects (of non-child bearing potential) with suitable veins for cannulation or repeated venipuncture

You may not qualify if…

• Inability to understand or cooperate with given information
• Positive human immune deficiency virus (HIV), Hepatitis B, or Hepatitis C test
• Clinically relevant abnormalities in physical examinations, vital signs, ECG, clinical chemistry, hematology, and urinanalysis

Where it is running

• Research Site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.